Stay updated on IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.

Latest updates to the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRecord history shows a new revision v3.3.2 was added and revision v3.2.0 was removed from the NCT02676869 record, indicating a minor maintenance/version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe government operating status notice about funding has been removed. All other study history content remains unchanged.SummaryDifference0.7%

- Check35 days agoChange DetectedThe Record History shows a minor update to the version list, while core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check64 days agoChange DetectedAdded a government funding notice and an updated software version (v3.2.0), removing the old v3.1.0; this primarily updates the page’s operating status guidance and versioning.SummaryDifference12%

- Check71 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.3%

- Check86 days agoChange DetectedVersion label updated from v3.0.1 to v3.0.2, signaling a minor release. The 'Back to Top' link was removed, a small UI change with little impact on content or functionality.SummaryDifference0.7%

Stay in the know with updates to IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.